Literatur
-
1
Agnelli G, Prandoni P, Santamaria M G. et al .
Three months versus one year
of oral anticoagulant therapy for idiopathic deep venous thrombosis.
Warfarin Optimal Duration Italian Trial Investigators.
N
Engl J Med.
2001;
345
165-169
-
2
Aschwanden M, Labs K H, Engel H. et al .
Acute deep vein thrombosis: early mobilization
does not increase the frequency of pulmonary embolism.
Thromb
Haemost.
2001;
85
42-46
-
3
Brandjes D P, Buller H R, Heijboer H. et al .
Randomised trial of effect of compression
stockings in patients with symptomatic proximal-vein thrombosis.
Lancet.
1997;
349
759-762
-
4
Breddin H K, Hach-Wunderle V, Nakov R, Kakkar V V.
Effects of
a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism
in patients with deep-vein thrombosis.
N Engl J Med.
2001;
344
626-631
-
5
Couturaud F, Julian J A, Kearon C.
Low
molecular weight heparin administered once versus twice daily in
patients with venous thromboembolism: a meta-analysis.
Thromb
Haemost.
2001;
86
980-984
-
6
Decousus H, Leizorovicz A, Parent F. et al .
A clinical trial of vena caval filters
in the prevention of pulmonary embolism in patients with proximal
deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire
par Interruption Cave Study Group.
N Engl J Med.
1998;
338
409-415
-
7
DGA-Leitlinien zur Diagnostik
und Therapie der Venenthrombose und Lungenembolie.
VASA.
2002;
31
(Suppl 60)
1-19
-
8
Dolovich L R, Ginsberg J S, Douketis J D. et al .
A meta-analysis comparing
low-molecular-weight heparins with unfractionated heparin in the
treatment of venous thromboembolism: examining some unanswered questions
regarding location of treatment, product type, and dosing frequency.
Arch
Intern Med.
2000;
160
181-188
-
9
Gonzalez-Fajardo J A, Arreba E, Castrodeza J. et al .
Venographic comparison of
subcutaneous low-molecular weight heparin with oral anticoagulant
therapy in the long-term treatment of deep venous thrombosis.
J
Vasc Surg.
1999;
30
283-292
-
10
Koopman M M, Prandoni P, Piovella F. et al. The Tasman Study Group .
Treatment of venous
thrombosis with intravenous unfractionated heparin administered
in the hospital as compared with subcutaneous low-molecular-weight
heparin administered at home.
N Engl J Med.
1996;
334
682-687
-
11
Leizorovicz A, Simonneau G, Decousus H. et al .
Comparison of efficacy and safety of low
molecular weight heparins and unfractionated heparin in initial
treatment of deep venous thrombosis: a meta-analysis.
BMJ.
1994;
309
299-304
-
12
Lensing A W, Prins M H, Davidson B L, Hirsh J.
Treatment
of deep venous thrombosis with low-molecular-weight heparins: A
meta-analysis.
Arch Intern Med.
1995;
155
601-607
-
13
Levine M N, Raskob G, Landefeld S, Kearon C.
Hemorrhagic complications
of anticoagulant treatment.
Chest.
2001;
119
(Suppl 1)
108S-121S
-
14
Lopaciuk S, Bielska-Falda H, Noszczyk W. et al .
Low molecular weight heparin versus acenocoumarol
in the secondary prophylaxis of deep vein thrombosis.
Thromb
Haemost.
1999;
81
26-31
-
15
Offermann M, Koepchen J, Graulich B.
Die
ambulante Therapie der akuten tiefen Beinvenenthrombose. Erfahrungen
aus zwei Praxen für Gefäßkrankheiten
in Deutschland.
Dtsch Med Wochenschr.
2001;
126
1164-1167
-
16
Schellong S M, Schwarz T, Kropp J. et al .
Bed rest in deep vein thrombosis
and the incidence of scintigraphic pulmonary embolism.
Thromb
Haemost.
1999;
82
127-129
-
17
Schwarz T, Schmidt B, Hohlein U. et al .
Eligibility for home treatment of deep
vein thrombosis: prospective study.
BMJ.
2001;
322
1212-1213
-
18
Veiga F, Escriba A, Maluenda M P. et al .
Low molecular weight heparin (enoxaparin)
versus oral anticoagulant therapy (acenocoumarol) in the long-term
treatment of deep venous thrombosis in the elderly: a randomized
trial.
Thromb Haemost.
2000;
84
559-564
-
19
Warkentin T E, Levine M N, Hirsh J. et al .
Heparin-induced thrombocytopenia
in patients treated with low-molecular-weight heparin or unfractionated
heparin.
N Engl J Med.
1995;
332
1330-1335
-
20
Wells P S, Forster A J.
Thrombolysis
in deep vein thrombosis: is there still an indication?.
Thromb
Haemost.
2001;
86
499-508
Priv.-Doz. Dr. med. R. Fries
Medizinische Klinik, Innere Medizin III, Universitätskliniken
des Saarlandes
66421 Homburg
Telefon: 06841/1623016
Fax: 06841/1623369
eMail: fries@med-in.uni-saarland.de
